BioArctic AB (publ)
BRCTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $26,132,857 | $16,155,096 | $16,085,192 | $17,881,816 |
| - Cash | $116,977 | $948,138 | $558,566 | $512,927 |
| + Debt | $4,931 | $48,991 | $50,992 | $54,228 |
| Enterprise Value | $26,020,811 | $15,255,949 | $15,577,618 | $17,423,117 |
| Revenue | $14,121 | $392,119 | $1,289,612 | $101,236 |
| % Growth | -96.4% | -69.6% | 1,173.9% | – |
| Gross Profit | $12,827 | $371,630 | $1,278,168 | $89,387 |
| % Margin | 90.8% | 94.8% | 99.1% | 88.3% |
| EBITDA | -$1,578 | $187,549 | $1,080,210 | -$43,247 |
| % Margin | -11.2% | 47.8% | 83.8% | -42.7% |
| Net Income | -$86,872 | $96,552 | $1,021,472 | -$31,462 |
| % Margin | -615.2% | 24.6% | 79.2% | -31.1% |
| EPS Diluted | -0.1 | 1.09 | 11.53 | -0.36 |
| % Growth | -109.2% | -90.5% | 3,302.8% | – |
| Operating Cash Flow | -$41,186 | $1,147,132 | $11,789 | -$27,367 |
| Capital Expenditures | $0 | -$120,678 | $0 | $0 |
| Free Cash Flow | -$41,186 | $1,147,132 | $11,789 | -$27,367 |